Florida Cancer Specialists & Research Institute

FCS provides comprehensive oncology and hematology care with access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs approved for use in the U.S. were studied at FCS prior to approval. The organization has received national recognition for quality care and cost-saving measures through value-based initiatives. Recent results include significant Medicare savings under the Oncology Care Model ($140M+ since program inception) while maintaining high-quality outcomes. Their research arm participates broadly across industry-sponsored and investigator-led studies with notable involvement in pivotal drug approvals. Example recent trial involvement includes combination immunotherapies such as petosemtamab plus pembrolizumab for recurrent/metastatic head & neck squamous cell carcinoma.